System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Yan Sun, MD is an expert in Nutrition at Maastricht University (Netherlands). Yan Sun has authored 11 publications, the most recent in 2026. SLR score: 58 (community average: 125). How the SLR is computed.

LeadR Profile

Yan Sun, MD Maastricht University Netherlands
58 ScienceLeadR Reputation 58

Unlock

Register Login
Network Map

Nutrition

Subspecialties: Oncology - Public Health - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

I am a PhD in Maastricht University, Netherlands, and an oncologist. My research primarily focuses on cancer cachexia, body composition, immunotherapy, and chemotherapy. I have experience in both clinical and translational research, having worked at leading institutions including Maastricht University, Shanghai Jiaotong University Ruijin Hospital Luwan Brunch, and Zhengzhou University. My work has been recognized with multiple awards and has been published in prestigious journals such as Clinical Nutrition. I am also actively involved in science communication, with over 300,000 followers on Chinese social media, where I share insights on cancer research and treatment.

Organizations

Career arc: 2020 - 2026
Source: PubMed

Maastricht University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 11

Citations

Citations: 5 1st author: 2 Last author: 1 Unique author: 0

Main journals

Clin Nutr ESPEN 2
J Clin Oncol 2
Ann Oncol 1
BMC Med 1
Clin Nutr 1

Best Journals

J Clin Oncol 2
Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
CREM Marks TCR-Driven T-Cell Activation and Associates with Favorable Prognosis in Papillary Thyroid Carcinoma: A Single-Cell and Bulk Transcriptomic Study.
PMID 42653390 — cells, thyroid cancer, papillary, genes, neoplasms, thyroid gland, genes, immediate-early, t-lymphocytes, prognosis		Int J Mol Sci20260
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990-2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023.
PMID 42612647 — nurses, health workforce, pharmacists, public health, global burden of disease, dentists, sex, occupations, cost of illness, retention, psychology, workforce		Lancet Public Health20261
Plasma metabolomics combined with machine learning for postoperative prognostic stratification in hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer.
PMID 42364806 — epidermal growth factor, growth, breast neoplasms, neoplasms, biomarkers, hormones, machine learning, receptors, growth factor, breast, metabolomics, learning, prognosis, plasma		Clin Nutr ESPEN20260
Subcutaneous adipose tissue radiation attenuation is associated with chemotoxicity and survival in metastatic colorectal cancer.
PMID 41864340 — muscles, subcutaneous fat, neoplasms, body composition, drug therapy, colorectal neoplasms, tissues, adipose tissue, chemotherapy		Clin Nutr ESPEN20260
Clinical and body composition parameters as predictors of response to chemotherapy plus PD-1 inhibitor in gastric cancer.
PMID 41126826 — neoplasms, body composition, drug therapy, immunotherapy, immune checkpoint inhibitors, weight loss, therapeutics, stomach neoplasms, chemotherapy		Front Immunol20250

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS